BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27193034)

  • 1. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.
    More VR; Campos CR; Evans RA; Oliver KD; Chan GN; Miller DS; Cannon RE
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1199-1212. PubMed ID: 27193034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.
    Wang X; Campos CR; Peart JC; Smith LK; Boni JL; Cannon RE; Miller DS
    J Neurosci; 2014 Jun; 34(25):8585-93. PubMed ID: 24948812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of breast cancer resistant protein by peroxisome proliferator-activated receptor α in human brain microvessel endothelial cells.
    Hoque MT; Robillard KR; Bendayan R
    Mol Pharmacol; 2012 Apr; 81(4):598-609. PubMed ID: 22266374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha.
    Moffit JS; Aleksunes LM; Maher JM; Scheffer GL; Klaassen CD; Manautou JE
    J Pharmacol Exp Ther; 2006 May; 317(2):537-45. PubMed ID: 16467456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.
    Mahringer A; Fricker G
    Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.
    Hartz AM; Mahringer A; Miller DS; Bauer B
    J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
    Miller DS
    Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
    Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
    Reichel V; Burghard S; John I; Huber O
    Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues.
    Lin F; Marchetti S; Pluim D; Iusuf D; Mazzanti R; Schellens JH; Beijnen JH; van Tellingen O
    Clin Cancer Res; 2013 Apr; 19(8):2084-95. PubMed ID: 23461902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
    Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
    Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABC transporter function and regulation at the blood-spinal cord barrier.
    Campos CR; Schröter C; Wang X; Miller DS
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1559-66. PubMed ID: 22472606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
    Durmus S; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Mol Pharm; 2012 Nov; 9(11):3236-45. PubMed ID: 23020847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats.
    Dazert P; Suofu Y; Grube M; Popa-Wagner A; Kroemer HK; Jedlitschky G; Kessler C
    Neuroscience; 2006 Nov; 142(4):1071-9. PubMed ID: 16997484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.